tiprankstipranks
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
PremiumThe FlyCompass Therapeutics price target raised to $7 from $5 at Ladenburg
1M ago
Compass Therapeutics reports Q3 EPS (8c), consensus (11c)
Premium
The Fly
Compass Therapeutics reports Q3 EPS (8c), consensus (11c)
1M ago
Compass Therapeutics sees cash runway into 1Q27
Premium
The Fly
Compass Therapeutics sees cash runway into 1Q27
1M ago
Compass Therapeutics completes patient enrollment in COMPANION-002
PremiumThe FlyCompass Therapeutics completes patient enrollment in COMPANION-002
5M ago
Compass Therapeutics Announces CEO Transition and New Leadership
Premium
Company Announcements
Compass Therapeutics Announces CEO Transition and New Leadership
7M ago
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
Premium
The Fly
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
7M ago
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
PremiumCompany AnnouncementsCompass Therapeutics’ CTX-009 Gains FDA Fast Track Status
8M ago
Compass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
Premium
The Fly
Compass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
8M ago
Compass Therapeutics presents data on combination of CTX-009, CTX-471
Premium
The Fly
Compass Therapeutics presents data on combination of CTX-009, CTX-471
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100